Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-09-30

Study Completion Date

2014-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Problems of compatibility between a mother and her child are frequent. The most well-known case can be illustrated by the fetomaternal blood group incompatibility (rhesus factor) which can induce severe anemia of the fetus.

The investigators recently proved that incompatibility between mother and child can concern an organ leading to a tissular alloimmunization. For example, neonatal membranous glomerulonephritis (a kidney disease) can result from this mechanism.

The purpose of this network is to detect and study neonatal diseases induced by tissular fetomaternal alloimmunization. The detection of these diseases will be performed by the mother's serum analysis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Validation of the IgA1 Detection Method With Gradient Glycosylation by Mass Spectrometry as a Potential Marker of Renal Involvement in Pediatric Rheumatoid Purpura

NCT04655378

Rheumatoid Purpura Pediatric ALL

COMPLETED

The Role of the Coagulation Pathways in Recurrent Angioedema

NCT02892682

Chronic Spotaneous Urticaria, Idiopathic Non Histaminergic Angioderma, Hereditary Angioedema With C1 Inhibitor Deficiency

TERMINATED NA

Study of Autoimmune Lymphoproliferative Syndrome (ALPS)

NCT00001350

Benign Lymphoproliferative Disorder

RECRUITING

Latent Viral Infection of Lymphoid Cells in Idiopathic Nephrotic Syndrome

NCT00577525

NEPHROSIS, LIPOID

COMPLETED

Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis

NCT02556866

Cryoglobulinemia Systemic Vasculitis

TERMINATED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glomerulonephritis, Membranous Neonatal Diseases and Abnormalities Hemochromatosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Mothers having a child suffering from:

* Neonatal membranous glomerulonephritis
* Unexplained neonatal tubular defect
* Unexplained thrombotic microangiopathy
* Neonatal hemochromatosis